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Abstract Scarce research has been performed to assess
whether the human maternal gut microbiota undergoes
changes during the perinatal period. Therefore, in the
present study, gut microbiota composition of seven healthy
mothers(to-be) was assessed at different time points during
the perinatal period (i.e. weeks 3–7 prepartum and days
3–6, 9–14, and 25–30 postpartum) using quantitative
polymerase chain reaction (qPCR) and pyrosequencing,
and was complemented by short-chain fatty acids (SCFA)
and calprotectin quantification using high-performance
liquid chromatography and enzyme-linked immunosorbent
assay, respectively. qPCR revealed the predominance of
members of the Firmicutes, Bacteroides, and Bifidobacte-
rium without detectable changes over the perinatal period.
Pyrosequencing supported these data in terms of microbi-
ota stability for any population at any taxonomic level,
although ratios of members of the Actinobacteria and
Bacteroidetes differed between the two methods. However,
the number of operational taxonomic units observed by
pyrosequencing was subjected to fluctuations and the rel-
ative abundance of Streptococcus decreased numerically
postpartum (P = 0.11), which may indicate that aberran-
cies in subdominant populations occur perinatally.
Furthermore, total fecal SCFA concentrations, particularly
the branched-chain fatty acids isobutyrate and isovalerate,
were higher than for non-pregnant subjects throughout the
perinatal period. This suggests metabolic changes and
increased energy extraction via proteolytic, in addition to
saccharolytic fermentation, accompanied by low-grade
inflammation based on fecal calprotectin levels. Our data
show that the maternal gut microbiota remained stable over
the perinatal period despite altered metabolic activity and
low-grade inflammation; however, it remains to be con-
firmed whether changes preceded earlier during pregnancy
and succeeded later postpartum.
Introduction
The human gut microbiota profoundly influences health
and disease throughout the life by complex microbe–
microbe and mutualistic host–microbe interactions [9]. A
healthy microbiota plays important functions in energy
harvest and storage, trophic and metabolic functions (e.g.
production of short-chain fatty acid (SCFA)), and protec-
tion against pathogens [15]. Moreover, the microbiota
interacts with mucosal epithelial cells, leading to matura-
tion and maintenance of the host immune system, which in
turn impacts the composition of the microbiota [28].
Consequently, microbial dysbiosis has been associated
with a range of immune-related and metabolic diseases,
including inflammatory bowel diseases, gastric cancer,
obesity, and type-2 diabetes [9].
Besides factors, such as diet, host genome, lifestyle,
disease, and medication, the gut microbiota has been
shown to undergo dramatic changes during early and late
life, but remains relatively stable in healthy adults [28].
However, recent studies have shown that the microbiota
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can become aberrant over the course of a healthy preg-
nancy, accompanied by metabolic changes that resemble
obesity-associated metabolic syndrome (e.g. reduced
insulin sensitivity, elevated blood glucose, and fecal cyto-
kine levels) [12, 23]. Collado et al. [12] reported signifi-
cantly increasing population levels from the first to the
third trimester of pregnancy using fluorescence in situ
hybridization coupled to flow cytometric detection (FISH-
FC) (i.e. total bacteria, Bifidobacterium spp., Clostridium
hystolyticum group, Bacteroides–Prevotella group), as well
as using quantitative polymerase chain reaction (qPCR)
(i.e. Bifidobacterium spp., Bacteroides fragilis, Staphylo-
coccus aureus, and Akkermansia muciniphila). Koren et al.
[23], when analyzing a subset of the same study cohort by
pyrosequencing, observed dramatic changes in microbiota
composition, involving loss of diversity and increasing
Proteobacteria and Actinobacteria populations from the
first to the third trimester of pregnancy, which persisted in
1 month postpartum samples. However, in contrast to
metabolic syndrome, the authors suggested these changes
to be beneficial during pregnancy and to support growth of
the fetus, as well as to prepare for energetic demands of
lactation.
In the present study, we used a narrower sampling
schedule compared with Koren et al. [23], focusing on the
gut microbiota composition during the perinatal period.
Therefore, the bacterial composition of maternal feces
collected during the third trimester of pregnancy and at
three time points within the first month postpartum was
analyzed using qPCR and pyrosequencing, and comple-
mented by quantification of glucose and metabolites (i.e.
SCFA and lactate) by high-performance liquid chroma-
tography (HPLC) and calprotectin, a marker of neutrophil
intestinal inflammation, and by enzyme-linked immuno-
sorbent assay (ELISA).
Methods
Study Design and Sample Collection
Healthy mothers-to-be carrying a healthy baby, and plan-
ning to deliver vaginally and to exclusively breast feed
during the neonatal period, were recruited for this obser-
vational clinical study by the University Children’s Hos-
pital Zurich and the Hospital Zollikerberg (Zurich,
Switzerland). Exclusion criteria were preterm and/or
cesarean delivery, any formula feeding, as well as any
variables known to affect the balance of the maternal
microbiota, including any dietary supplementation (e.g.
probiotic supplements) and drug administration (e.g. anti-
biotics) during lactation and at least four months prepar-
tum. This study was conducted according to the guidelines
laid down in the Declaration of Helsinki, and all proce-
dures involving human subjects were approved by the
Ethics Committee of the Canton of Zurich (Zurich, Swit-
zerland) (project identification code: StV47/08; date of
approval: 12.10.2009) and written informed consent was
obtained from all subjects.
A total of 21 healthy mothers-to-be were recruited for
this study, however, due to the stringent inclusion criteria,
12 mothers-to-be were excluded before the first postpartum
sampling point and 2 mothers thereafter, mainly due to
cesarean delivery and/or antibiotic treatment. Thus,
maternal feces were successfully collected from seven
mothers(-to-be) (aged 34.1 ± 3.9 years) at four sampling
points, i.e. at 3–7 weeks prepartum and at days 3–6, 9–14,
and 25–30 postpartum.
Fresh feces were collected into fecal collection con-
tainers provided with an anaerobic gas generation system
that creates a CO2 atmosphere, while chemically binding
O2 (Anaerocult A, Merck KGaA, Darmstadt, Germany).
Samples were transported at 4 C, aliquoted in an anaer-
obic chamber (Coy Laboratory Products Inc., Grass Lake,
MI, USA) with the atmosphere of 85 % N2, 10 % CO2,
and 5 % H2, and stored at -80 C within 4 h upon
sampling.
DNA Extraction
Total DNA was extracted from 0.2 g of fecal aliquots using
a FastDNA SPIN Kit for Soil and the FastPrep-24 instru-
ment for mechanical lysis (MP Biomedicals, Illkirch,
France) according to the manufacturer’s instructions. DNA
concentration and quality were assessed spectrophotomet-
rically and aliquots were stored at -20 C prior to the
molecular analyses.
Quantitative PCR
Different qPCR assays were performed, using a 7500 Fast
Real-Time PCR System with SYBR Green chemistry
(Applied Biosystems Europe BV, Zug, Switzerland), for
the absolute quantification of the major gut-associated
bacterial populations, Bacteroides, Bifidobacterium, Fir-
micutes, Roseburia and Eubacterium rectale, Faecalibac-
terium prausnitzii, Lactobacillus, Streptococcus,
Staphylococcus, Enterobacteriaceae, and total bacteria.
The corresponding primer sets targeted the 16S rRNA
gene, except for the Bifidobacterium assay, in which the
xylulose-5-phosphate/fructose-6-phosphate phosphoketo-
lase gene (xfp) was targeted, as well as for the Staphylo-
coccus and Streptococcus assays, in both of which the gene
encoding the elongation factor Tu (tuf) was targeted. The
advantage of the xfp and tuf assays is that they overcome
the 16S rRNA gene multiple copy number bias [25], as
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only one copy of the xfp gene has been detected in Bifi-
dobacterium spp. to date, and low-GC gram-positive bac-
teria, such as Staphylococcus and Streptococcus spp.,
generally contain only one copy of the tuf gene [11, 22].
Primer sequences, reaction mixtures, cycling conditions,
and melt curve analysis have been described in detail
previously [19]. Type strain DNA for the generation of
standard curves consisted of purified 16S rRNA gene
amplicons of Bacteroides thetaiotaomicron DSM2079T;
Lactobacillus delbrueckii DSM20081T; Escherichia coli
DSM5698; and Faecalibacterium prausnitzii DSM17677 for
the Bacteroides, Lactobacillus, Enterobacteriaceae, and
Faecalibacterium assays, respectively, and Roseburia in-
testinalis, DSM14610T for both the Firmicutes and Roseb-
uria assays; while, plasmid pLME21 containing the 16S
rRNA gene from Bifidobacterium lactis, DSM10140T was
used in the total bacteria assay, the xfp amplicon of Bifido-
bacterium longum DSM20219T for the Bifidobacterium
assay, and the tuf amplicon of Staphylococcus epidermidis,
DSM20044T and Streptococcus mitis, DSM12643T in the
Staphylococcus and Streptococcus assays, respectively.
Sample gene copy numbers per gram of wet feces were
extrapolated from standard curves generated in triplicate in
each run by linear regression of Ct values from serial tenfold
dilutions of appropriate type strain DNA.
Pyrosequencing
Total fecal DNA was used for unidirectional barcoded
pyrosequencing of the V5–V6 hypervariable 16S rRNA
region, which was chosen since the V6 region exhibits the
highest sequence variability and therefore, a high dis-
criminatory power [1]. Reactions were carried out at
DNAVision SA (Charleroi, Belgium), using a 454 Life
Sciences GS FLX system in combination with Titanium
chemistry (Roche AG, Basel, Switzerland) as described
previously [19, 20].
Sequence quality was verified according to the criteria:
maximum of one mismatch in the barcode and primer,
length of at least 240 bp, and a maximum of two unde-
termined bases per sequence (excluding barcode and
primers). The dataset has been deposited to the National
Center for Biotechnology Information (NCBI) Sequence
Read Archive (SRA) under accession number SRA065797.
Phylum-, family- and genus-level taxonomic assignments
of quality-controlled sequences were made using the
Ribosomal Database Project (RDP) Classifier [36] with a
stringent confidence threshold of 80 %. The Mothur soft-
ware package was used for nearest neighbor clustering of
the sequences into operational taxonomic units (OTU),
based on which richness (Chao index and rarefaction
curves) and diversity (Shannon index) were calculated
[7, 32].
HPLC and ELISA
Fecal concentrations of SCFA, acetate, butyrate, formate,
propionate and valerate, branched-chain fatty acids
(BCFA), isobutyrate and isovalerate, as well as glucose and
lactate were measured by HPLC as described previously
[10], and reported as mM fecal water. Fecal calprotectin
concentrations were measured by ELISA (Eurospital SpA,
Trieste, Italy) according to the manufacturer’s instructions
and reported as lg g-1 feces. Calprotectin is a highly
stable antimicrobial protein accounting for *60 % of the
soluble cytosol proteins in neutrophils. Thus, its concen-
tration correlates with the intensity of intestinal neutrophil
infiltration and can be considered as reliable, noninvasive
method for assessing intestinal inflammation [6].
Statistical Analysis
Quantitative data obtained from qPCR (triplicates) were
averaged and log10-transformed, while ratios of individual
populations over total bacteria were calculated from
absolute values. For statistical analysis, mean log10-trans-
formed qPCR data, mean relative abundance and OTU data
from pyrosequencing, mean metabolites and calprotectin
concentrations were calculated at each time point
(mean ± SD), and differences over time were assessed by
one-way repeated measures ANOVA and Tukey post-test
using Prism 5 (GraphPad Software Inc, La Jolla, CA, USA)
with significance levels of P \ 0.05.
Results
Quantitative PCR
Quantification of the major gut-associated bacterial popu-
lations using qPCR showed that the maternal fecal micro-
biota was dominated by members of the Firmicutes phylum
at all four sampling points during the perinatal period
(overall mean of 10.6 ± 0.5 log gene copies/g feces, rep-
resenting about 32 % of total bacteria) including the genera
Faecalibacterium and Roseburia (overall means of
9.7 ± 0.6 and 9.6 ± 0.7 log gene copies/g feces, i.e. each
*5 % of total bacteria) followed by Bacteroides and lower
counts of Bifidobacterium (overall means of 10.3 ± 0.7
and 8.9 ± 0.6 log gene copies/g feces, i.e. *14 and
*0.6 %) of total bacteria, respectively) (Table 1). Enter-
obacteriaceae, Lactobacillus, and Streptococcus were
observed at subdominant levels only (7.4 ± 0.9, 7.7 ± 1.7
and 5.6 ± 3.0 log gene copies/g feces i.e. each B0.02 % of
total bacteria), and Staphylococcus population levels were
below the detection limit in all but one sample. Population
densities detected for total bacteria, Bifidobacterium,
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Bacteroides, Firmicutes, Faecalibacterium, Roseburia, and
Enterobacteriaceae did not vary significantly from the
third trimester of pregnancy (3–7 weeks prepartum)
throughout the first month postpartum (Table 1).
High inter-individual variations in population densities
(and thus high standard deviations, i.e. [1 log unit) were
observed for Lactobacillus and Streptococcus, however, no
significant differences were detected over time for both of
these populations, nor for any other population (Table 1).
Pyrosequencing
High-throughput sequencing performed on maternal fecal
DNA generated a total of 278,084 quality-filtered, taxo-
nomically classifiable 16S rRNA gene sequence reads with
a mean of 9,932 ± 2,474 reads per sample, and mean read
lengths of 258 ± 1 bp. The slopes of the rarefaction curves
generated at 3, 5, and 10 % OTU dissimilarity cut-off,
which are generally accepted cut-offs for species, genus,
and family/class level differentiation, respectively, level-
off toward the right, indicating that the majority of the
diversity has been covered and that a considerable addi-
tional sequencing effort would be required to detect addi-
tional OTU (Fig. 1). The overall mean OTU number at 3 %
similarity cut-off was 842 ± 331, based on which richness
and diversity were calculated (Chao1 index: 1,924 ± 829
and Shannon index: 4.41 ± 0.49, respectively). However,
the mean number of observed OTU at 3 % similarity cut-
off was 875 ± 363 prepartum, and 956 ± 479, 734 ± 265,
and 803 ± 221 over the three sampling points during the
first month postpartum. Thus, OTU numbers varied during
the perinatal period, however, these variations were not
significant over time (P = 0.12). The same variations were
observed for richness and diversity indexes over time.
Phylum-level taxonomic classification using RDP clas-
sifier revealed that the Firmicutes and Actinobacteria
dominated the maternal microbiota (overall mean relative
abundance of 84.9 ± 10.5 and 11.6 ± 9.7 %, respec-
tively), followed by the Bacteroidetes and Proteobacteria
phyla (1.5 ± 2.2 and 0.8 ± 3.4 %, respectively) (Fig. 2a).
Classification at the family-level (Fig. 2b) and genus-level
(Fig. 3) showed the highest diversity within the Firmicutes
phylum, comprising six families and thirteen genera that
were detected at overall mean relative abundances of C1
and C0.5 %, respectively. However, members of the
Lachnospiraceae family (Blautia, Coprococcus, Dorea and
Roseburia) and the Ruminococcaceae family (Faecali-
bacterium, Ruminococcus and Subdoligranulum) domi-
nated the maternal microbiota. In contrast, less diversity
was observed for the other three phyla: the Actinobacteria
phylum comprised members of the Bifidobacteriaceae
(Bifidobacterium) and Coriobacteriaceae families (Collin-
sella). The Bacteroidetes and Proteobacteria phyla com-
prised only members of the Bacteroidaceae (Bacteroides)
and Enterobacteriaceae families (Escherichia/Shigella),
respectively, which was reflected in their mean relative
abundance pattern at all taxonomic levels (Figs. 2a, b, 3).
Despite that no statistically significant variations in
mean relative abundances over time were observed at any
taxonomic level, both Streptococcaceae and Streptococcus
decreased numerically over the perinatal period (P = 0.13
and 0.11, respectively), which is in agreement with data
obtained from qPCR; while on the other hand, Dialister
increased numerically over the perinatal period (P = 0.43).
Table 1 Quantification of the major gut-associated bacterial populations by qPCR
Target population MF0 MF1 MF2 MF3 P valuea
Total bacteria 11.1 ± 0.4 10.9 ± 0.5 11.2 ± 0.8 11.2 ± 0.4 0.74
Bifidobacterium 9.0 ± 0.5 8.7 ± 0.6 8.8 ± 0.6 9.0 ± 0.5 0.36
Bacteroides 10.1 ± 0.5 10.2 ± 0.6 10.3 ± 0.9 10.5 ± 0.5 0.51
Firmicutes 10.6 ± 0.4 10.5 ± 0.4 10.6 ± 0.7 10.7 ± 0.3 0.89
Faecalibacterium 9.6 ± 0.4 9.7 ± 0.4 9.8 ± 0.9 9.6 ± 0.5 0.84
Roseburia 9.3 ± 0.6 9.6 ± 0.4 10.0 ± 0.8 9.7 ± 0.6 0.19
Lactobacillus 8.3 ± 1.1 7.6 ± 1.0 7.1 ± 3.0 8.0 ± 0.4 0.56
Staphylococcus n.d.b n.d. 1.7 ± 3.0c n.d. 0.44
Streptococcus 6.4 ± 2.7 5.0 ± 3.2 6.2 ± 2.6 4.9 ± 3.1 0.36
Enterobacteriaceae 7.6 ± 0.9 7.2 ± 0.8 7.3 ± 0.7 7.6 ± 0.6 0.44
Gene copy numbers detected in maternal feces during pregnancy (MF0, i.e. 3–7 weeks prepartum) and lactation (MF1, MF2, and MF3, i.e. days
4–6, 9–14, and 25–28 postpartum, respectively; N = 7 at each time point). Values are expressed as mean ± SD log gene copy numbers/g feces
a differences over time were assessed by one-way repeated measures ANOVA with significance levels of P \ 0.05
b not detected
c one positive sample only at 6.8 log gene copies/g feces
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HPLC and ELISA
Assessment of fecal metabolites using HPLC revealed that
overall mean total SCFA concentration was 156.6 ±
27.1 mM. The most abundant SCFA was acetate (overall mean
of 79.8 ± 19.2 mM), followed by isobutyrate, butyrate, and
propionate (24.6 ± 12.3, 23.0 ± 6.6, and 18.4 ± 5.7 mM,
respectively), while all other metabolites, as well as glucose,
were detected at lower concentrations (overall means\6 mM)
(Fig. 4). Fecal calprotectin was detected at an overall mean
concentration of 18.8 ± 6.1 lg g-1 feces using ELISA
(Fig. 4). No significant differences in any fecal SCFA, glucose,
lactate, or calprotectin were detected over time.
Discussion
Scarce research has been performed to assess whether the
maternal gut microbiota undergoes changes during the
perinatal period. In the present study, we used state-of-the-
art molecular methods, qPCR and pyrosequencing, and
successfully characterized the bacterial composition of
feces collected from seven mothers at four time points
during the perinatal period.
Quantitative PCR revealed that the major gut-associated
bacterial populations did not undergo detectable changes
throughout the perinatal period. Members of the Firmicutes
and Bacteroides predominated the maternal microbiota,
followed by Bifidobacterium, while facultative anaerobic
populations, Enterobacteriaceae, Streptococcus, and Lac-
tobacillus were detected at subdominant levels. These
population levels largely reflect the composition of a
healthy adult gut microbiota [31], which indicates that
delivery and lactation do not induce significant alteration of
the gut microbiota.
Compared with absolute quantification by qPCR,
assessment of the mean relative population abundances by
pyrosequencing at phylum-, family-, and genus-level,
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Fig. 1 Rarefaction curves showing the number of observed OTU at a 3 %, b 5 %, and c 10 % dissimilarity cut-off as a function of the number of
pyrosequences, which are generally accepted cut-offs for species, genus, and family/class level differentiation, respectively
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Fig. 2 Phylum- and family-level gut microbiota composition assessed
by pyrosequencing. Mean relative 16S rRNA gene abundances detected
in maternal feces during pregnancy (MF0, i.e. 3–7 weeks prepartum)
and lactation (MF1, MF2, and MF3, i.e. days 4–6, 9–14, and 25–28
postpartum, respectively; N = 7 at each time point). a Taxonomic
assignments at the phylum-level and b at the family-level considering
phyla and families detected at an overall mean relative abundance C0.5
and C1 %, respectively (N = 28). Values are expressed as mean ±
SD. The abbreviations A, B, and P stand for the phyla Actinobacteria,
Bacteroidetes, and Proteobacteria, respectively
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allowed gaining a more comprehensive insight into the
predominant bacterial diversity. Pyrosequencing supported
qPCR data in terms of microbiota stability throughout the
perinatal period for any population at any taxonomic level,
which is consistent with the fact that Koren et al. [23] did
not observe significant changes in microbiota composition
between the third trimester of pregnancy and one month
postpartum. However, differences in some population
levels were observed between those methods: both methods
confirmed the predominance of members of the Firmicutes,
but ratios of Bacteroidetes and Actinobacteria phyla,
comprising mainly Bacteroides and Bifidobacterium,
respectively, were inversed. The high quantitative accuracy
of qPCR and the fact that the Firmicutes and Bifidobacte-
rium levels detected in the present study are consistent with
previous research using qPCR on healthy, non-pregnant
subjects [3, 16, 26, 33], suggest an underestimation of
Bacteroidetes and/or overestimation of Actinobacteria by
pyrosequencing due to primer bias rather than due to DNA
extraction, since the same extracts have been used for both
methods. The mean relative phylum-level abundances
detected in the present study are consistent with the pre-
vious pyrosequencing analyses of fecal samples from
healthy subjects [1, 35]. Andersson et al. [1], using the
same primers targeting the V5-V6 16S rRNA gene region,
suggested an underestimation of Bacteroidetes and a higher
primer snsitivity for Actinobacteria. On the other hand,
Collado et al. [12], when analyzing for the first time the gut
microbiota during pregnancy using qPCR and FISH,
detected slightly higher Bifidobacterium compared with
Bacteroides–Prevotella group levels and an increase in
both populations from the first to the third trimester of
pregnancy. In line with these findings, Koren et al. [23]
reported an increase in Actinobacteria pyrosequences
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during pregnancy when analyzing a subset of the same
study cohort. It remains, however, to be elucidated whether
differences between these and our study are attributable to
methodological factors (e.g. DNA extraction procedures),
nutritional (e.g. probiotic consumption) and/or geographic
factors as pointed out in previous research [14, 37], or if an
inversed ratio of Actinobacteria to Bacteroidetes may be
attributable to changes in host-microbiota interactions
during pregnancy. It should be noted that the abundance of
Bacteroidetes detected by qPCR and pyrosequencing (i.e.
*14 and *1.5 %) was relatively low compared with
several previous studies where abundances of up to*50 %
have been detected [2, 4, 34]. This discrepancy may be
explained by the DNA extraction procedure, which
involved a relatively harsh beat beating step that may have
partly destroyed shear sensitive gram-negative bacteria,
such as members of the Bacteroidetes. On the other hand,
the relatively low abundance of the Firmicutes detected by
qPCR compared with pyrosequencing (i.e. 32 and 84.9 %,
respectively) may be explained by the difficulty in
designing primers that are specific to all members of a
group as diverse as the Firmicutes, whereas specificity is
less of an issue for the design of universal bacterial
primers.
Variations in mean OTU number and relative abundance
of facultative anaerobes, such as Streptococcus and mem-
bers of the Proteobacteria observed over time using py-
rosequencing, although not statistically significant, may
indicate that aberrancies in subdominant populations occur
perinatally. Koren et al. [23] reported a reduction in OTU
(loss of diversity) from the first to the third trimester,
accompanied by an increase in Proteobacteria. In this
context, the slight decrease in Escherichia/Shigella, as well
as Streptococcus during the perinatal period in our study
may thus reflect resilience to normal physiologic popula-
tion and diversity levels. It should be noted that no Shigella
are expected in the group reported as Escherichia/Shigella,
however, the length of the pyrosequences is not sufficient
for differentiating between those closely related genera.
Assessment of SCFA concentrations by HPLC revealed
as expected acetate, butyrate, and propionate as major
metabolic products resulting from saccharolytic bacterial
fermentation. Although, ratios of individual to total SCFA
concentrations corresponded largely to those reported
previously for non-pregnant subjects, except BCFA, total
SCFA concentrations were higher than those detected in
both normal-weight and obese subjects (i.e. 156.6 ± 27.1
vs 124.9 ± 31.5 and 142.8 ± 28.6 mM, respectively) [29].
Furthermore, concentrations of the BCFA, isobutyrate and
isovalerate, which result from proteolytic fermentation and
usually represent only a minor fraction of total SCFA,
surprisingly exceeded those reported previously [29]. This
suggests metabolic changes and highly efficient dietary
energy extraction, which has been hypothesized as bene-
ficial in the context of pregnancy [23]. This observation is
moreover supported by the fact that fecal glucose (i.e.
4.1 ± 3.1 mM) was similarly depleted as in obese (i.e.
4.3 ± 5.2 mM), while considerably higher concentrations
have been observed in normal-weight subjects (i.e.
26.6 ± 61.7 mM) [29]. One explanation for increased
energy extraction may be an increase in gastrointestinal
transit time due to hormonal (i.e. increased progesterone
and estradiol levels) and metabolic changes during late
pregnancy, as reported previously [8, 24]. In contrast to
butyrate, whose beneficial functions on colonocytes have
been studied extensively [17], it remains to be elucidated
whether isobutyrate is beneficial or harmful to colonocytes.
Despite that butyrate is preferentially metabolized by col-
onocytes, research has shown that colonocytes are able to
metabolize isobutyrate under conditions of low butyrate
concentrations [18], which may be a reason for fecal
isobutyrate accumulation observed in our study.
In the present study, fecal calprotectin levels were
assessed as a marker of intestinal inflammation by ELISA,
and no significant differences over the perinatal period could
be observed. Costa et al. [13] reported median fecal calpro-
tectin levels of 11 lg g-1 (95 % CI 3–18 lg g-1) in healthy
subjects versus *22 lg g-1 (95 % CI 9–35 lg g-1) in
patients with inflammatory bowel disease. Thus, mean levels
observed in the present study (18.8 ± 6.1 lg g-1) may
represent low-grade signs of intestinal inflammation, which
has also been observed by Koren et al. [23] on the basis of
elevated pro-inflammatory cytokine levels during the third
trimester of pregnancy. Low-grade inflammation may
reduce epithelial barrier integrity [5], which would support
the hypothesis of increased bacterial translocation during
pregnancy, and the presence of a bacterial entero-mammary
pathway as a novel way of mother-neonate communication
via breast-feeding, as proposed previously [20, 21, 27, 30].
The use of both qPCR and pyrosequencing, as bench-
mark for absolute bacterial quantification and diversity
assessment, respectively, at four different time points
during the perinatal period is a major strength of the
present study. Compared with the study by Koren et al.
[23], a higher mean number of pyrosequences was gener-
ated per sample (*2,873 vs *9,932), allowing to gain
deeper insight into subdominant populations, which may
also explain the higher OTU number observed in the
present study. On the other hand, sample size was smaller
in the present study, which limits statistical power. Fur-
thermore, although the observation of stability of the
maternal microbiota from the third trimester of pregnancy
to one month postpartum is consistent with the previous
research [23], the first trimester samples would be required
in future research to confirm the changes observed by
Koren et al. [23] and Collado et al. [12].
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In conclusion, in the present study, we observed quan-
titative or qualitative stability of the maternal gut micro-
biota throughout the perinatal period, despite that OTU
number was subjected to fluctuations. Furthermore, ele-
vated fecal SCFA and calprotectin concentrations suggest
metabolic changes and low-grade inflammation, which in
contrast to obesity has been hypothesized as beneficial in
the context of a healthy pregnancy [23]. However, in future
research these observations should be verified based on a
larger number of subjects, extended sampling schedule
(including non-pregnant controls), and methodology (e.g.
functional genomics), to confirm whether changes in mic-
robiota composition and metabolism preceded earlier dur-
ing pregnancy and succeeded later postpartum.
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